Ghali JK, Wikstrand J, Van Veldhuisen DJ, Fagerberg B, Goldstein S, Hjalmarson A et al. The influence of renal function on clinical outcome and response to beta-blockade in systolic heart failure: insights from Metoprolol CR/XL Randomized Intervention Trial in Chronic HF (MERIT-HF). Journal of Cardiac Failure. 2009; 15(4):310-8 131. Giordano A, Scalvini S, Zanelli E, Corra U, Longobardi GL, Ricci VA et al. Multicenter randomised trial on home-based telemanagement to prevent hospital readmission of patients with chronic heart failure. International Journal of Cardiology. 2009; 131(2):192-199 132. Girerd N, Collier T, Pocock S, Krum H, McMurray JJ, Swedberg K et al. Clinical benefits of eplerenone in patients with systolic heart failure and mild symptoms when initiated shortly after hospital discharge: analysis from the EMPHASIS-HF trial. European Heart Journal. 2015; 133. Glogowska M, Simmonds R, McLachlan S, Cramer H, Sanders T, Johnson R et al. Managing patients with heart failure: A qualitative study of multidisciplinary teams with specialist heart failure nurses. Annals of Family Medicine. 2015; 13(5):466-471 134. Goldberg LR, Piette JD, Walsh MN, Frank TA, Jaski BE, Smith AL et al. Randomized trial of a daily electronic home monitoring system in patients with advanced heart failure: the Weight Monitoring in Heart Failure (WHARF) trial. American Heart Journal. 2003; 146(4):705-712 135. Goldstein NE, Mehta D, Siddiqui S, Teitelbaum E, Zeidman J, Singson M et al. "That's like an act of suicide" patients' attitudes toward deactivation of implantable defibrillators. Journal of 136. Goldstein NE, Mehta D, Teitelbaum E, Bradley EH, Morrison RS. "It's like crossing a bridge" complexities preventing physicians from discussing deactivation of implantable defibrillators at the end of life. Journal of General Internal Medicine. 2008; 23 (Suppl 1):2-6 137. Gonzalez-Guerrero JL, Alonso-Fernandez T, Garcia-Mayolin N, Gusi N, Ribera-Casado JM. 